Possible Celiac Disease Nanotechnology Treatment Breakthrough Revealed

October 24, 2019

(Newsweek) – The results of a clinic trial suggest medical nanotechnology could lead to new effective treatments for celiac disease and a rash of other ailments. The treatment, called CNP-101/TAK-101, was developed at Northwestern University. It utilizes microscopic nanoparticles in an attempt to train the body’s immune system to tolerate gluten. Celiac is an autoimmune disorder that results in a person’s immune system being unable to tolerate the protein gluten, triggering inflammatory attacks on the digestive system when the substance is introduced.